569PISO-CC-005; A phase I/II study of arfolitixorin (MTHF) in combination with 5-FU, irinotecan, and oxaliplatin ± bevacizumab in patients with metastasizing colorectal cancer. (23rd October 2018) - Carlsson, G U; Guren, T K; Haux, J; Pfeiffer, P; Taflin, H; Mavroudis, D; Georgoulias, V; Papadimitriou, C; Kentepozidis, N; Boumpas, D; Skintemo, L; Ganlöv, K M E; et al.